XML 58 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Description of the business - Narrative (Detail)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Mar. 13, 2023
USD ($)
$ / shares
shares
Jan. 06, 2023
USD ($)
shares
Dec. 13, 2021
shares
Nov. 30, 2022
USD ($)
Aug. 31, 2018
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
employee
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Sep. 30, 2021
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Conversion ratio           0.3333     0.3333
Net loss           $ 254,153 $ 292,213 $ 120,114  
Net cash used in operating activities           237,134 $ 207,034 $ 67,793  
Cash, cash equivalents, and marketable securities           $ 267,700      
ATM Facility | Cowen and Company, LLC                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Aggregate gross proceeds (up to)       $ 150,000          
Regeneron Collaboration Agreement | Share purchase agreement                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Issuance of common stock to Regeneron (in shares) | shares     100,000            
Gross proceeds from private placement offering         $ 100,000        
Price per shares (in dollars per share) | $ / shares         $ 238.10        
Subsequent Event | Underwritten Public Offering                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Shares issued in underwritten public offering (in shares) | shares 10,900,000                
Price per shares (in dollars per share) | $ / shares $ 11.50                
Gross proceeds from public offering $ 125,000                
Additional shares available for purchase (in shares) | shares 1,630,434                
Subsequent Event | Regeneron Collaboration Agreement | Share purchase agreement                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Issuance of common stock to Regeneron (in shares) | shares   1,114,827              
Gross proceeds from private placement offering   $ 20,000              
2seventy bio Securities Corporation                  
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]                  
Number of employees | employee           0